SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB: NVLX) announces discussions are at an advanced stage with one of the world’s most experienced cell therapy companies to acquire their pancreatic cancer treatment technology.
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB: NVLX) announces discussions are at an advanced stage with one of the world’s most experienced cell therapy companies to acquire their pancreatic cancer treatment technology.
